South Korea bone graft and substitutes market to see 4% CAGR until 2033

The growing prevalence of orthopaedic conditions is boosting the market’s demand.

South Korea’s bone graft and substitutes market is projected to expand at a compound annual growth rate of 4% through 2033, said GlobalData.

The sector’s growth is attributed to the rising demand for advanced bone regeneration solutions due to an increasing prevalence of orthopaedic conditions like osteoarthritis, osteoporosis, and trauma-related injuries.

However, conventional bone grafts often lack sufficient adhesive strength and face difficulties maintaining their shape in complex cases, said Jyoti Sharma, Medical Devices Analyst at GlobalData.

“Novel products, such as injectable hydrogels, are expected to offer promising advancements by addressing these gaps and enhancing outcomes in bone defect management,” Sharma added.

South Korea accounted for about 5% of the Asia Pacific market share in 2024.